Entrada Therapeutics, Inc. (TRDA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$157.90M | -435.9% |
| 2024 | $47.01M | +1586.7% |
| 2023 | -$3.16M | +96.7% |
| 2022 | -$97.25M | -90.2% |
| 2021 | -$51.13M | -91.7% |
| 2020 | -$26.67M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$157.90M | -435.9% |
| 2024 | $47.01M | +1586.7% |
| 2023 | -$3.16M | +96.7% |
| 2022 | -$97.25M | -90.2% |
| 2021 | -$51.13M | -91.7% |
| 2020 | -$26.67M | — |